M35氧化诱导阿贝塔42中的类似阿贝塔40的结构和动态变化
Yilin Yan1, Scott A McCallum, Chunyu Wang
1Biology Department, Center for Biotechnology and Interdisciplinary Studies, Rensselear Polytechnic Institute, Troy, New York 12180, USA.
Journal of the American Chemical Society
|April 2, 2008
概括
在粉胺β (Abeta) 中氧化氨酸35 (M35) 会减缓聚合并降低毒性. 这种氧化导致Abeta42采用类似于Abeta40的结构变化,解释了其减少的有害影响.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 粉样蛋白-β (Abeta) 聚合成纤维是阿尔茨海默氏症病原体的核心.
- 阿贝塔中氨酸残留物的氧化是一种已知的翻译后修饰.
- 氨酸35 (M35) 是Abeta42聚合中的一个关键残留物.
研究的目的:
- 阐明M35氧化影响Abeta42结构,动态,聚合和毒性的分子机制.
- 为了研究在Abeta42.2.中M35氧化引起的结构和动态变化.
主要方法:
- 计算建模和模拟用于分析结构和动态变化.
- 生物化学测定以评估聚合动力学和毒性.
主要成果:
- 在Abeta42中M35的氧化显著提高了C端残留物的移动性.
- M35氧化导致阿贝塔42.4的中心疏水群的灵活性下降.
- 这些结构和动态变化导致Abeta42.2的延迟聚合和降低细胞毒性.
- 氧化阿贝塔42 (Abeta42ox) 具有类似于阿贝塔40.0的特性.
结论:
- 在M35的阿贝塔42氧化会产生类似阿贝塔40的结构和动态特性.
- 这些修改导致了观察到的Abeta42聚合和毒性降低.
- 准M35氧化是阿尔茨海默氏症潜在的治疗策略.
更多相关视频
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
相关概念视频
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
